TIDMIDEA

RNS Number : 5822I

Ideagen PLC

01 September 2016

1 September 2016

Ideagen plc

("Ideagen" or the "Company")

Exercise of Options and Total Voting Rights

Ideagen PLC (AIM: IDEA), a leading supplier of Information Management Software to highly regulated industries, announces that it has allotted 110,000 new ordinary shares of 1 penny each in the capital of the Company ("Ordinary Shares") following the exercise of share options by an employee.

Application has been made to the London Stock Exchange for the 110,000 new Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will become effective and trading will commence at 8.00 a.m. on 6(th) September 2016.

After Admission, the total number of Ordinary Shares in issue will be 180,004,428 and the total number of voting rights will therefore be 180,004,428. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

 
     Enquiries: 
     Ideagen plc                             Tel: 01629 699100 
     David Hornsby, Chief Executive 
     Graeme Spenceley, Finance 
      Director 
 
     finnCap (Nominated Adviser              Tel: 020 7220 0500 
      and Broker) 
     Stuart Andrews / James Thompson 
      (Corporate Finance) 
     Stephen Norcross (Corporate 
      Broking) 
 
     Alma PR 
     Hilary Buchanan                         Tel: 07780 901979 
     Josh Royston                            Tel: 07515 805218 
 

About Ideagen plc

Ideagen is a UK company quoted on the London Stock Exchange AIM market (Ticker: IDEA.LN). Ideagen is a supplier of Information Management software with operations in the UK, the United States and the Middle East. The Company specialises in eGRC (Enterprise Governance, Risk and Compliance) and Healthcare solutions for organisations operating within highly regulated industries. With an excellent portfolio of software products, Ideagen is able to provide complete content lifecycle solutions that enable organisations to meet their Regulatory and Quality Compliance standards, helping them to reduce costs and improve efficiency.

The Group has a customer base of over 2,200 organisations using the Ideagen suite of products, including many blue chip names such as BAE Systems, Emirates, Shell and the European Central Bank as well as 150 hospitals in the UK and US.

For further information please visit www.ideagen.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCLLFIVTRILVIR

(END) Dow Jones Newswires

September 01, 2016 02:00 ET (06:00 GMT)

Ideagen (LSE:IDEA)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Ideagen Charts.
Ideagen (LSE:IDEA)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Ideagen Charts.